Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 15Breast 3Thoracic 2Lymphoid 2Tumor-Agnostic 1Plasma cell 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 3Pain, Postoperative 1Hand-Foot Syndrome 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Diclofenac × Breast × Clear all
NCT05641246 2024-01-03

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

German University in Cairo

Phase 2 Completed
86 enrolled
Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT05829707 2023-04-28

Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia

Osijek University Hospital

Phase 4 Completed
120 enrolled
Breast

Breast Neoplasms, Pain, Postoperative

NCT04511832 2022-07-20

Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors

China Medical University Hospital

Phase NA Completed
54 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡